GlycoMimetics, Inc

(NASDAQ:GLYC)

Latest On GlycoMimetics, Inc (GLYC):

Date/Time Type Description Signal Details
2023-05-30 15:17 ESTNewsGlycoMimetics: Insider Buying Continues, And Chart Looks HealthyN/A
2023-05-10 16:14 ESTNewsGlycoMimetics: An Asymmetric Opportunity That Could Change HematologyN/A
2023-05-04 00:06 ESTNewsGlycoMimetics, Inc. (GLYC) Q1 2023 Earnings Call TranscriptN/A
2023-05-03 10:57 ESTNewsGlycoMimetics GAAP EPS of -$0.17 in-lineN/A
2023-04-04 15:04 ESTNewsGlycoMimetics Has Few Risks, Great Outlook In LeukemiaN/A
2023-03-29 13:01 ESTNewsGlycoMimetics GAAP EPS of -$0.19 misses by $0.02N/A
2023-03-29 13:00 ESTNewsGlycoMimetics, Inc. (GLYC) Q4 2022 Earnings Call TranscriptN/A
2023-03-13 13:57 ESTNewsRAPT Therapeutics, Repare Therapeutics among biotechs to disclose exposure to Silicon Valley BankN/A
2023-03-09 01:56 ESTNewsGlycoMimetics: Stock Price Drop Brings Great Speculative Trade OpportunityN/A
2023-02-22 13:21 ESTNewsGlycoMimetics slips as chief scientific officer departsN/A
2023-02-18 18:22 ESTNewsStocks To Watch: Retail Gets Tested With Walmart, Home Depot And CAGNY Conference On TapN/A
2023-02-17 16:57 ESTNewsGlycoMimetics: Unraveling The Tea LeavesN/A
2023-02-15 11:21 ESTNewsGlycoMimetics sheds 39% after 11.8M stock offeringN/A
2023-01-03 16:22 ESTNewsGlycoMimetics: A Cancer-Cure Lottery Ticket Grabbing My AttentionN/A
2022-11-12 05:25 ESTNewsGlycoMimetics Could Surge If Q1 Data Readout Is PositiveN/A
2022-11-10 00:37 ESTNewsGlycoMimetics GAAP EPS of -$0.16 beats by $0.10N/A
2022-11-10 00:36 ESTNewsGlycoMimetics, Inc. (GLYC) Q3 2022 Earnings Call TranscriptN/A
2022-09-06 09:09 ESTNewsGlycoMimetics has a new Chief Medical OfficerN/A
2022-08-03 21:08 ESTNewsGlycoMimetics GAAP EPS of $0.25 beats by $0.53, revenue of $75KN/A
2022-08-03 21:07 ESTNewsGlycoMimetics, Inc. (GLYC) CEO Harout Semerjian on Q2 2022 Results - Earnings Call TranscriptN/A
2022-04-30 17:59 ESTNewsGlycoMimetics, Inc. (GLYC) CEO Harout Semerjian on Q1 2022 Results - Earnings Call TranscriptN/A
2022-04-28 13:35 ESTNewsGlycoMimetics GAAP EPS of -$0.28 beats by $0.03N/A
2022-04-27 22:51 ESTNewsGlycoMimetics Q1 2022 Earnings PreviewN/A
2022-03-17 10:10 ESTNewsGlycoMimetics Positive Data For AML Therapy Increasingly LikelyN/A
2022-03-17 10:09 ESTNewsGlycoMimetics' Uproleselan: Secondary Reasons To Own The StockN/A
2022-03-04 23:25 ESTNewsGlycoMimetics files for $250M mixed shelf offeringN/A
2022-03-03 12:03 ESTNewsGlycoMimetics GAAP EPS of -$0.33 beats by $0.01, revenue of $0.18MN/A
2022-03-03 12:02 ESTNewsGlycoMimetics, Inc. (GLYC) CEO Harout Semerjian on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-02 17:47 ESTNewsGlycoMimetics Q4 2021 Earnings PreviewN/A
2021-11-12 21:45 ESTNewsGlycoMimetics A Buy On Nearing Trial Enrollment CompletionN/A
2021-11-02 16:41 ESTNewsGlycoMimetics reports Q3 resultsN/A
2021-11-02 16:40 ESTNewsGlycoMimetics, Inc. (GLYC) CEO Harout Semerjian on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-01 20:02 ESTNewsGlycoMimetics Q3 2021 Earnings PreviewN/A
2021-09-26 20:14 ESTNewsGlycoMimetics (GLYC) Investor Presentation - SlideshowN/A
2021-09-24 05:04 ESTNewsGlycoMimetics shares jump 12% after highlighting promising data from uproleselan leukemia trialN/A
2021-08-08 12:49 ESTNewsGlycoMimetics, Inc. (GLYC) CEO Rachel King on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-06 03:42 ESTNewsGlycoMimetics EPS beats by $0.03N/A
2021-08-05 05:21 ESTNewsGlycoMimetics names Harout Semerjian as chief executive officerN/A
2021-07-23 00:09 ESTNewsTreatment gets underway in early-stage leukemia trial of GlycoMimetics' uproleselanN/A
2021-07-21 10:27 ESTNewsGlycoMimetics says first patient dosed in investigator-sponsored mid-stage uproleselan studyN/A
2021-07-21 09:54 ESTNewsDosing gets underway in GlycoMimetics' uproleselan combination leukemia studyN/A
2021-05-03 23:14 ESTNewsGlycoMimetics, Inc. (GLYC) CEO Rachel King on Q1 2021 Results - Earnings Call TranscriptN/A
2021-03-04 11:44 ESTAnalyst RatingThe Analyst Target Price has decreased from $10.5 to $10.25.Neutral
2021-03-04 07:43 ESTFinancialsCompany financials have been released.Neutral
2021-03-03 11:42 ESTEarnings EstimateAn EPS average of -$1.36 is estimated for the 2022 year.Sell
2021-03-03 11:42 ESTEarnings EstimateAn EPS average of -$0.31 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-03 07:24 ESTNewsGlycoMimetics, Inc.'s (GLYC) CEO Rachel King on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-02 13:01 ESTNewsGlycoMimetics EPS in-line, misses on revenueN/A
2021-02-23 14:50 ESTNewsGlycoMimetics picks internal candidate for chief medical officerN/A
2020-12-08 11:54 ESTAnalyst RatingThe Analyst Target Price has increased from $9 to $10.5.Buy

About GlycoMimetics, Inc (GLYC):

GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. The company's drug candidate include rivipansel, a pan-selectin antagonist for the treatment of vaso-occlusive crisis in sickle cell disease. It is also developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as Phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing GMI-1359 to target E-selectin and a chemokine receptors. It also develops various other programs, including GMI-1687, an antagonist of E-selectin; and Galectin-3, a carbohydrate-binding protein. The company has a cooperative research and development agreement with the National Cancer Institute; and collaboration and license agreement with Apollomics for the development and commercialization of uproleselan and GMI-1687. GlycoMimetics, Inc. was founded in 2003 and is headquartered in Rockville, Maryland.

GLYC Quotes by TradingView

See Advanced Chart

General

  • Name GlycoMimetics, Inc
  • Symbol GLYC
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 54
  • Fiscal Year EndDecember
  • IPO Date2014-01-10
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://glycomimetics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 15.03
  • Price/Book (Most Recent Quarter) 1.34
  • Enterprise Value Revenue 3.72
  • Enterprise Value EBITDA 0.09
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.28
  • Next Year EPS Estimate -$1.40
  • Next Quarter EPS Estimate -$0.33
  • Operating Margin -507%
  • Return on Assets -21%
  • Return on Equity -36%
  • Revenue 10.16 million
  • Earnings Per Share -$1.28
  • Revenue Per Share $0.22
  • Gross Profit 10.16 million
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 177.14 million
  • EBITDA -59150020
  • Analyst Target Price $10.25
  • Book Value Per Share $2.62
View More

Share Statistics

  • Shares Outstanding 51.49 million
  • Shares Float 31.78 million
  • % Held by Insiders 215%
  • % Held by Institutions 78.59%
  • Shares Short 1.07 million
  • Shares Short Prior Month 919111
  • Short Ratio 1.15
  • Short % of Float 4%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 2.4
  • 52 Week High $5.19
  • 52 Week Low $1.94
  • 50 Day Moving Average 3.61
  • 200 Day Moving Average 3.56
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

GlycoMimetics, Inc (GLYC) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

GlycoMimetics, Inc (GLYC) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-02$163000-$0.32-$0.320.62%
2020-09-302020-11-06$N/A-$0.29-$0.328.43%
2020-06-302020-07-31$N/A-$0.32-$0.3713.51%
2020-03-312020-05-01$N/A-$0.18-$0.2937.93%
2019-12-312020-02-28$N/A-$0.34-$0.353.41%
2019-09-302019-11-07$N/A-$0.31-$0.4123.46%
2019-06-302019-08-01$N/A-$0.37-$0.370%
2019-03-312019-05-02$N/A-$0.33-$0.367.3%
2018-12-312019-03-06$N/A-$0.32-$0.31-3.9%
2018-09-302018-11-02$N/A-$0.27-$0.3216.49%
2018-06-302018-08-09$N/A-$0.26-$0.3422.96%
2018-03-312018-05-03$N/A-$0.33-$0.28-17.86%
2017-12-312018-03-06$N/A-$0.27-$0.25-8.87%
2017-09-302017-11-08$N/A-$0.24-$0.3018.64%
2017-06-302017-08-03$N/A-$0.30-$0.3514.29%
2017-03-312017-05-08$N/A-$0.34-$0.365.56%
2016-12-312017-03-01$-500-$0.36-$0.360%
2016-09-302016-11-04$19000-$0.34-$0.4218.07%
2016-06-302016-08-04$N/A-$0.41-$0.4814.58%
2016-03-312016-05-04$N/A-$0.40-$0.4613.04%
2015-12-312016-02-29$36000-$0.47-$0.470%
2015-09-302015-11-12$-20035000-$0.38-$0.405%
2015-06-302015-08-06$20.04 million$0.51-$0.40227.5%
2015-03-312015-05-05$N/A-$0.37-$0.370%
2014-12-312015-03-16$15.03 million-$0.39-$0.22-77.27%
2014-09-302014-10-31$-15027000-$0.35$0.21-266.67%
2014-06-302014-07-31$15.03 million$0.39$0.2462.5%
2014-03-312014-05-09$23.59 million-$0.30-$0.300%

GlycoMimetics, Inc (GLYC) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

GlycoMimetics, Inc (GLYC) Chart:

GlycoMimetics, Inc (GLYC) News:

Below you will find a list of latest news for GlycoMimetics, Inc (GLYC) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

GlycoMimetics, Inc (GLYC) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-05-160.50.04CALL4 13373.36FALSE0.040
2025-05-1610.05CALL0 50FALSE00
2025-05-161.50CALL0 0639.42FALSE00
2025-05-1620CALL0 0793.76FALSE00
2025-05-162.50CALL0 0830.76FALSE00
2025-05-1650CALL0 0831FALSE00
2025-05-167.50CALL0 00FALSE00
2025-05-160.50PUT0 0146.37TRUE00
2025-05-1610PUT0 00TRUE00
2025-05-161.50PUT0 00TRUE00
2025-05-1620PUT0 00TRUE00
2025-05-162.50PUT0 00TRUE00
2025-05-1654.9PUT0 70TRUE00
2025-05-167.57.4PUT0 80TRUE00
2025-06-200.50.05CALL0 1170190.01FALSE00
2025-06-2010.05CALL0 215478.17FALSE00
2025-06-201.50.05CALL0 80FALSE00
2025-06-2020.05CALL0 40FALSE00
2025-06-202.50.05CALL0 10FALSE00
2025-06-2050.05CALL0 0515.89FALSE00
2025-06-207.50.05CALL0 26472.03FALSE00
2025-06-200.50.25PUT0 9199.38TRUE00
2025-06-2010.7PUT0 120TRUE00
2025-06-201.51.22PUT0 160TRUE00
2025-06-2020PUT0 00TRUE00
2025-06-202.50PUT0 00TRUE00
2025-06-2054.9PUT0 60TRUE00
2025-06-207.57.4PUT0 50TRUE00
2025-09-190.50.05CALL264 2431158.67FALSE-0.05-0.5
2025-09-1910.05CALL0 210FALSE00
2025-09-191.50CALL0 00FALSE00
2025-09-1920CALL0 00FALSE00
2025-09-192.50.05CALL0 600FALSE00
2025-09-1950CALL0 00FALSE00
2025-09-197.50.01CALL0 310FALSE00
2025-09-190.50.39PUT0 2393294.5TRUE00
2025-09-1910.75PUT0 1710TRUE00
2025-09-191.50PUT0 00TRUE00
2025-09-1920PUT0 00TRUE00
2025-09-192.50PUT0 00TRUE00
2025-09-1950PUT0 00TRUE00
2025-09-197.50PUT0 00TRUE00
2025-12-190.50.1CALL1 110186.74FALSE0.10
2025-12-1910CALL0 00FALSE00
2025-12-191.50CALL0 00FALSE00
2025-12-1920CALL0 00FALSE00
2025-12-192.50CALL0 00FALSE00
2025-12-1950CALL0 00FALSE00
2025-12-197.50CALL0 00FALSE00
2025-12-190.50.35PUT0 52201.12TRUE00
2025-12-1910PUT0 0441.17TRUE00
2025-12-191.50PUT0 00TRUE00
2025-12-1920PUT0 00TRUE00
2025-12-192.50PUT0 00TRUE00
2025-12-1950PUT0 00TRUE00
2025-12-197.50PUT0 00TRUE00

Latest GLYC Trades:

Date Shares Price
Jun 13, 2022 5:30 PM EST100$0.6216
Jun 13, 2022 6:41 PM EST85$0.6287
Jun 13, 2022 7:01 PM EST100$0.6216
Jun 13, 2022 7:58 PM EST100$0.6066
Jun 13, 2022 7:58 PM EST100$0.6066

GlycoMimetics, Inc (GLYC) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120032315/0001209191-20-032315-index.htm
2019-05-23UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1253689/000000000019008876/0000000000-19-008876-index.htm
2019-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000003877719000032/0000038777-19-000032-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000008025519002657/0000080255-19-002657-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000008025520001261/0000080255-20-001261-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000021545719006611/0000215457-19-006611-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000031506619001057/0000315066-19-001057-index.htm
2019-08-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000031506619001676/0000315066-19-001676-index.htm
2019-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000031506619001702/0000315066-19-001702-index.htm
2018-09-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000072888918001483/0000728889-18-001483-index.htm
2019-01-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000072888919000038/0000728889-19-000038-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000083423720005369/0000834237-20-005369-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000090221919000165/0000902219-19-000165-index.htm
2020-01-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000090221920000035/0000902219-20-000035-index.htm
2020-04-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000090221920000372/0000902219-20-000372-index.htm
2019-06-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000091420819000279/0000914208-19-000279-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000091420820000058/0000914208-20-000058-index.htm
2020-04-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000091420820000283/0000914208-20-000283-index.htm
2020-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000091420820000361/0000914208-20-000361-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000092189518000663/0000921895-18-000663-index.htm
2019-08-15SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000092189519002247/0000921895-19-002247-index.htm
2019-08-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000092189519002332/0000921895-19-002332-index.htm
2019-09-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000092189519002380/0000921895-19-002380-index.htm
2019-09-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000092189519002381/0000921895-19-002381-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000092189520000539/0000921895-20-000539-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000092189520002779/0000921895-20-002779-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000092189520002828/0000921895-20-002828-index.htm
2020-07-20SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000093583620000390/0000935836-20-000390-index.htm
2018-03-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1253689/000104746918001847/0001047469-18-001847-index.htm
2018-03-21424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1253689/000104746918001954/0001047469-18-001954-index.htm
2019-05-17S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1253689/000104746919003186/0001047469-19-003186-index.htm
2020-10-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1253689/000104746920005139/0001047469-20-005139-index.htm
2018-03-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000110465918019322/0001104659-18-019322-index.htm
2019-05-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1253689/000110465919031465/0001104659-19-031465-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000114420419008076/0001144204-19-008076-index.htm
2018-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118009860/0001209191-18-009860-index.htm
2018-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118029614/0001209191-18-029614-index.htm
2018-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118029615/0001209191-18-029615-index.htm
2018-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118029616/0001209191-18-029616-index.htm
2018-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118029619/0001209191-18-029619-index.htm
2018-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118031812/0001209191-18-031812-index.htm
2018-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118031817/0001209191-18-031817-index.htm
2018-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118031825/0001209191-18-031825-index.htm
2018-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118031836/0001209191-18-031836-index.htm
2018-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118031842/0001209191-18-031842-index.htm
2018-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118031858/0001209191-18-031858-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118033068/0001209191-18-033068-index.htm
2018-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118037288/0001209191-18-037288-index.htm
2018-10-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118055586/0001209191-18-055586-index.htm
2018-11-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118060156/0001209191-18-060156-index.htm
2018-11-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118060160/0001209191-18-060160-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119004821/0001209191-19-004821-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119004823/0001209191-19-004823-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119004825/0001209191-19-004825-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119004827/0001209191-19-004827-index.htm
2019-03-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119017473/0001209191-19-017473-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119031714/0001209191-19-031714-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119031716/0001209191-19-031716-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119031718/0001209191-19-031718-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119031720/0001209191-19-031720-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119031725/0001209191-19-031725-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119031734/0001209191-19-031734-index.htm
2019-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119044967/0001209191-19-044967-index.htm
2019-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119046095/0001209191-19-046095-index.htm
2019-12-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119061782/0001209191-19-061782-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120002098/0001209191-20-002098-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120004814/0001209191-20-004814-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120004818/0001209191-20-004818-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120004824/0001209191-20-004824-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120004826/0001209191-20-004826-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120004828/0001209191-20-004828-index.htm
2020-03-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120017836/0001209191-20-017836-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120032299/0001209191-20-032299-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120032302/0001209191-20-032302-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120032304/0001209191-20-032304-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120032308/0001209191-20-032308-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120032311/0001209191-20-032311-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120032315/0001209191-20-032315-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000142573818000010/0001425738-18-000010-index.htm
2018-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837018001530/0001558370-18-001530-index.htm
2018-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1253689/000155837018001553/0001558370-18-001553-index.htm
2018-03-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1253689/000155837018001557/0001558370-18-001557-index.htm
2018-04-13DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1253689/000155837018002958/0001558370-18-002958-index.htm
2018-05-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837018003834/0001558370-18-003834-index.htm
2018-05-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1253689/000155837018003836/0001558370-18-003836-index.htm
2018-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837018004900/0001558370-18-004900-index.htm
2018-07-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837018005686/0001558370-18-005686-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1253689/000155837018006888/0001558370-18-006888-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837018006892/0001558370-18-006892-index.htm
2018-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837018008313/0001558370-18-008313-index.htm
2018-11-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1253689/000155837018008314/0001558370-18-008314-index.htm
2018-11-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837018009486/0001558370-18-009486-index.htm
2019-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837019001513/0001558370-19-001513-index.htm
2019-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1253689/000155837019001537/0001558370-19-001537-index.htm
2019-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837019001547/0001558370-19-001547-index.htm
2019-03-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1253689/000155837019001578/0001558370-19-001578-index.htm
2019-04-10DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1253689/000155837019002905/0001558370-19-002905-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837019003802/0001558370-19-003802-index.htm
2019-05-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1253689/000155837019003803/0001558370-19-003803-index.htm
2019-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837019005190/0001558370-19-005190-index.htm
2019-08-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1253689/000155837019006741/0001558370-19-006741-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837019006743/0001558370-19-006743-index.htm
2019-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837019007085/0001558370-19-007085-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1253689/000155837019010290/0001558370-19-010290-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837019010292/0001558370-19-010292-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837019011165/0001558370-19-011165-index.htm
2020-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837020000060/0001558370-20-000060-index.htm
2020-02-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837020000636/0001558370-20-000636-index.htm
2020-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1253689/000155837020001723/0001558370-20-001723-index.htm
2020-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837020001731/0001558370-20-001731-index.htm
2020-02-28S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1253689/000155837020001772/0001558370-20-001772-index.htm
2020-04-16DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1253689/000155837020003935/0001558370-20-003935-index.htm
2020-05-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1253689/000155837020004879/0001558370-20-004879-index.htm
2020-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837020004881/0001558370-20-004881-index.htm
2020-05-08DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1253689/000155837020005890/0001558370-20-005890-index.htm
2020-05-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837020006971/0001558370-20-006971-index.htm
2020-07-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1253689/000155837020008841/0001558370-20-008841-index.htm
2020-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837020008848/0001558370-20-008848-index.htm
2020-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837020011405/0001558370-20-011405-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1253689/000155837020013021/0001558370-20-013021-index.htm
2020-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837020013033/0001558370-20-013033-index.htm
2019-08-15SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000165495419009665/0001654954-19-009665-index.htm
2019-05-28EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1253689/999999999519001225/9999999995-19-001225-index.htm

GlycoMimetics, Inc (GLYC) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of GlycoMimetics, Inc (GLYC). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 215%
Institutional Ownership: 7859%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-06-11Brian M. HahnCFOSell19,345.0018.04348,983.800.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118037288/0001209191-18-037288-index.htm
2018-05-23John L. MagnaniSVP of Research, CSOBuy1,491.000.33492.03100,793.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118033068/0001209191-18-033068-index.htm
2019-08-13DANIEL M JUNIUSDirectorBuy10,000.003.1831,800.0018,000.00https://www.sec.gov/Archives/edgar/data/1253689/000120919119046095/0001209191-19-046095-index.htm
2019-12-20John L. MagnaniSVP of Research, CSOBuy106,984.001.12119,822.08182,777.00https://www.sec.gov/Archives/edgar/data/1253689/000120919119061782/0001209191-19-061782-index.htm
2018-06-11Brian M. HahnCFOBuy5,260.001.125,891.2019,345.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118037288/0001209191-18-037288-index.htm
2020-01-06John L. MagnaniSVP of Research, CSOBuy106,983.001.12119,820.96289,760.00https://www.sec.gov/Archives/edgar/data/1253689/000120919120002098/0001209191-20-002098-index.htm
2019-09-05PARTNERS L P/IL BVF10% Share HolderBuy689,834.003.182,195,051.792,955,440.00https://www.sec.gov/Archives/edgar/data/1253689/000092189519002381/0000921895-19-002381-index.htm
2019-08-06Rachel K. KingPresident, CEOBuy166,759.001.12186,770.08307,144.00https://www.sec.gov/Archives/edgar/data/1253689/000120919119044967/0001209191-19-044967-index.htm
2020-10-30PARTNERS L P/IL BVF10% Share HolderBuy250,755.002.75689,576.253,206,195.00https://www.sec.gov/Archives/edgar/data/1253689/000092189520002779/0000921895-20-002779-index.htm
2019-09-05PARTNERS L P/IL BVF10% Share HolderBuy853,956.003.182,717,287.993,639,935.00https://www.sec.gov/Archives/edgar/data/1253689/000092189519002381/0000921895-19-002381-index.htm
2020-11-04PARTNERS L P/IL BVF10% Share HolderBuy506,155.002.601,316,003.003,712,350.00https://www.sec.gov/Archives/edgar/data/1253689/000092189520002828/0000921895-20-002828-index.htm
2020-03-09DANIEL M JUNIUSDirectorBuy20,000.003.4068,000.0038,000.00https://www.sec.gov/Archives/edgar/data/1253689/000120919120017836/0001209191-20-017836-index.htm
2020-10-30PARTNERS L P/IL BVF10% Share HolderBuy666,385.002.751,832,558.754,306,320.00https://www.sec.gov/Archives/edgar/data/1253689/000092189520002779/0000921895-20-002779-index.htm
2018-05-10ENTERPRISE ASSOCIATES 10 L P NEW10% Share HolderSell4,006.0017.8171,346.864,702,791.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118029614/0001209191-18-029614-index.htm
2018-05-10M JAMES BARRETTDirectorSell4,006.0017.8171,346.864,702,791.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118029615/0001209191-18-029615-index.htm
2018-05-10PETER J BARRIS10% Share HolderSell4,006.0017.8171,346.864,702,791.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118029616/0001209191-18-029616-index.htm
2018-05-10SCOTT D SANDELL10% Share HolderSell4,006.0017.8171,346.864,702,791.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118029619/0001209191-18-029619-index.htm
2020-11-04PARTNERS L P/IL BVF10% Share HolderBuy674,492.002.601,753,679.204,980,812.00https://www.sec.gov/Archives/edgar/data/1253689/000092189520002828/0000921895-20-002828-index.htm
2018-05-10ENTERPRISE ASSOCIATES 10 L P NEW10% Share HolderSell5,533.0017.8198,542.734,995,664.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118029614/0001209191-18-029614-index.htm
2018-05-10M JAMES BARRETTDirectorSell5,533.0017.8198,542.734,995,664.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118029615/0001209191-18-029615-index.htm
2018-05-10PETER J BARRIS10% Share HolderSell5,533.0017.8198,542.734,995,664.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118029616/0001209191-18-029616-index.htm
2018-05-10SCOTT D SANDELL10% Share HolderSell5,533.0017.8198,542.734,995,664.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118029619/0001209191-18-029619-index.htm
2019-09-05PARTNERS L P/IL BVF10% Share HolderBuy124,956.003.18397,609.99528,891.00https://www.sec.gov/Archives/edgar/data/1253689/000092189519002381/0000921895-19-002381-index.htm
2020-10-30PARTNERS L P/IL BVF10% Share HolderBuy15,472.002.7542,548.00544,363.00https://www.sec.gov/Archives/edgar/data/1253689/000092189520002779/0000921895-20-002779-index.htm
2020-11-04PARTNERS L P/IL BVF10% Share HolderBuy86,090.002.60223,834.00630,453.00https://www.sec.gov/Archives/edgar/data/1253689/000092189520002828/0000921895-20-002828-index.htm
2018-10-18John L. MagnaniSVP of Research, CSOSell3,527.0014.0249,448.5475,793.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118055586/0001209191-18-055586-index.htm
2018-10-17John L. MagnaniSVP of Research, CSOSell7,273.0014.00101,822.0079,320.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118055586/0001209191-18-055586-index.htm
2018-10-16John L. MagnaniSVP of Research, CSOSell14,200.0014.01198,942.0086,593.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118055586/0001209191-18-055586-index.htm